XERIS BIOPHARMA HOLDINGS INC

XERSNASDAQ

🏆 #1961 by market capEarnings Nov 5US Equity

$10.75▲ $0.11 (+1.03%)

🌙 After hours$10.74▼ 0.11%Regular close · extended-hours price shown

🔔

Track XERS

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 1.0%

7d▲ 5.5%

14d▲ 4.1%

30d▲ 12.6%

ytd▲ 37.1%

1y▲ 10.7%

🏦Market Cap

$1.96B

Small Cap

📈Revenue Growth (YoY)

36.3%

High Growth

📊Gross Margin

86.6%

High

💵FCF Margin

16.6%

Healthy

⚖️P/S Ratio

6.1x

Fair

Otter Score

Strong

XERIS BIOPHARMA HOLDINGS INC

XERS

Analyst Ratings

Price

$10.75

Total

Raised

Lowered

Avg PT

$15.00

H / L

$16 / $14

Institution	Action	Rating	Date		Upside
Barclays	Reiterated	Overweight	2026-10-06	$14.00	+30.20%
Leerink Partners	Reiterated	Outperform	2026-09-10	$16.00	+48.80%
HC Wainwright & Co.	Reiterated	Buy	2026-03-02	—	—
Piper Sandler	Reiterated	Neutral	2025-11-07	$4.00	−62.80%
Oppenheimer	Reiterated	Outperform	2025-11-07	$18.00	+67.40%
Craig-Hallum	Reiterated	Buy	2025-08-08	$6.50	−39.50%
Jefferies	Reiterated	Buy	2025-01-29	—	—
SVB Leerink	Reiterated	Outperform	2023-01-27	—	—
Mizuho	Reiterated	Buy	2022-03-16	—	—
RBC Capital	Reiterated	Outperform	2018-07-16	—	—
Leerink Swann	Reiterated	Outperform	2018-07-16	—	—

Institution

Barclays

Reiterated · Overweight · 2026-10-06

$14.00

+30.20%

Leerink Partners

Reiterated · Outperform · 2026-09-10

$16.00

+48.80%

HC Wainwright & Co.

Reiterated · Buy · 2026-03-02

—

Piper Sandler

Reiterated · Neutral · 2025-11-07

$4.00

−62.80%

Oppenheimer

Reiterated · Outperform · 2025-11-07

$18.00

+67.40%

Craig-Hallum

Reiterated · Buy · 2025-08-08

$6.50

−39.50%

Jefferies

Reiterated · Buy · 2025-01-29

—

SVB Leerink

Reiterated · Outperform · 2023-01-27

—

Mizuho

Reiterated · Buy · 2022-03-16

—

RBC Capital

Reiterated · Outperform · 2018-07-16

—

Leerink Swann

Reiterated · Outperform · 2018-07-16

—

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space